Recruiting
Phase 2

Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors

Sponsor:

Emory University

Code:

NCT04469530

Conditions

Solid Tumor

Eligibility Criteria

Sex: All

Age: 1 - 30

Healthy Volunteers: Not accepted

Interventions

Sirolimus

Cyclophosphamide

Etoposide

Celecoxib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information